Valeant Pharma Posts Q2 Profit Loss, Soars on Positive Outlook
August 09, 2016 at 16:53 PM EDT
Total revenues came in at $2.4 billion, lagging behind our consensus estimate of $2.592 billion and falling 11.4% year-over-year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.